Skip to main content
. 2020 Nov 26;20:1158. doi: 10.1186/s12885-020-07633-3

Fig. 2.

Fig. 2

CD133+ HPCs enhances breast cancer cell proliferation and reduces their apoptosis in vitro. Data show representative flow cytometry charts, or present the mean ± SD of each group from three separate experiments. a The proliferation of cells; b The images of apoptotic cells; c Quantitative analysis of apoptotic cells. *P < 0.05, compared with CD133- HUCBCs group